🇺🇸 FDA
Patent

US 11103436

Peptide exhibiting wrinkle-improving activity and uses thereof

granted A61KA61K38/00A61K38/08

Quick answer

US patent 11103436 (Peptide exhibiting wrinkle-improving activity and uses thereof) held by CAREGEN CO., LTD. expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CAREGEN CO., LTD.
Grant date
Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/00, A61K38/08, A61K8/64